Global MicroRNA profiling of pancreatic neuroendocrine Neoplasias

Anticancer Research

Volumn 34, Issue 5, 2014, Pages 2249-2254

  Thorns, Chistoph ^a   Schurmann, Claudia ^b   Gebauer, Niklas ^a   Wallaschofski, Henri ^c   Kümpers, Christiane ^a   Bernard, Veronica ^a   Feller, Alfred C ^a   Keck, Tobias ^a   Habermann, Jens K ^a   Begum, Nehara ^a   Lehnert, Hendrik ^a   Brabant, Georg ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

MicroRNA; MiR 193b; Pancreatic neuroendocrine neoplasia; Serum

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; MICRORNA; MICRORNA 146B; MICRORNA 193B; MICRORNA 210; MICRORNA 642; MICRORNA 720; UNCLASSIFIED DRUG; TRANSCRIPTOME; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; MICRODISSECTION; MITOSIS; PANCREAS; PANCREAS ISLET; PANCREATIC NEUROENDOCRINE TUMOR; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; DNA MICROARRAY; GENETICS; METHODOLOGY; MIDDLE AGED; MIR-193B; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PANCREATIC NEUROENDOCRINE NEOPLASIA; SERUM; VERY ELDERLY;

MICRORNA; MIR-193B; PANCREATIC NEUROENDOCRINE NEOPLASIA; SERUM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEUROENDOCRINE TUMORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84902967350     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fraenkel M, Kim MK, Faggiano A and Valk GD: Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 26: 691-703, 2012.
2. Bosman FT, Carneiro F, Hruban RH, Theise ND: WHO Classification of Tumours of the Digestive System: IARC, 2010.
3. Franko J, Feng W, Yip L, Genovese E and Moser AJ: Nonfunctional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2, 158 patients. J Gastrointest Surg 14: 541-548, 2010.
4. Sadaria MR, Hruban RH and Edil BH: Advancements in pancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol 7: 477-490, 2013.
5. de Laat JM, Pieterman CR, Weijmans M, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR and Valk GD: Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients. J Clin Endocrinol Metab 98: 4143-4151, 2013.
6. Oberg K, Casanovas O, Castano JP, Chung D, Delle Fave G, Denefle P, Harris P, Khan MS, Kulke MH, Scarpa A, Tang LH and Wiedenmann B: Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches. Clin Cancer Res 19: 2842-2849, 2013.
7. Zhang J, Francois R, Iyer R, Seshadri M, Zajac-Kaye M and Hochwald SN: Current understanding of the molecular biology of pancreatic neuroendocrine tumors. J Natl Cancer Inst 105: 1005-1017, 2013.
8. Modlin IM, Drozdov I and Kidd M: The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood. PLoS One 8: e63364, 2013.
9. Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in human cancer. Adv Exp Med Biol 774: 1-20, 2013.
10. Pencheva N and Tavazoie SF: Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 15: 546-554, 2013.
11. Sita-Lumsden A, Dart DA, Waxman J and Bevan CL: Circulating microRNAs as potential new biomarkers for prostate cancer. Br J Cancer 108: 1925-1930, 2013.
12. Redova M, Sana J and Slaby O: Circulating miRNAs as new blood-based biomarkers for solid cancers. Future Oncol 9: 387-402, 2013.
13. Ruebel K, Leontovich AA, Stilling GA, Zhang S, Righi A, Jin L and Lloyd RV: MicroRNA expression in ileal carcinoid tumors: down-regulation of microRNA-133a with tumor progression. Mod Pathol 23: 367-375, 2010.
14. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A and Croce CM: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684, 2006.
15. Li SC, Essaghir A, Martijn C, Lloyd RV, Demoulin JB, Oberg K and Giandomenico V: Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors. Mod Pathol 26: 685-696, 2013.
16. Edge SB BD, Compton CC, Fritz AG, Green FL, Trotti A AJCC Cancer Staging Manual 7th edition: Springer, 2010.
17. Taguchi YH and Murakami Y: Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers. PLoS One 8: e66714, 2013.
18. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, Meyer HE and Reifenberger G: Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20: 539-550, 2010.
19. Yuan Y, Shen Y, Xue L and Fan H: miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor. PLoS One 8: e73604, 2013.
20. Yang H, Fang F, Chang R and Yang L: MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology 58: 205-217, 2013.
21. Zhang Y, Eades G, Yao Y, Li Q and Zhou Q: Estrogen receptor alpha signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem 287: 41514-41522, 2012.
22. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T, Shimizu N and Sawada K: The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 25: 1324-1334, 2011.
23. Thorns C, Kuba J, Bernard V, Senft A, Szymczak S, Feller AC and Bernd HW: Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma. Virchows Arch 460: 371-377, 2012.
24. Cai J, Liu X, Cheng J, Li Y, Huang X, Ma X, Yu H, Liu H and Wei R: MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2. Graefes Arch Clin Exp Ophthalmol 250: 523-531, 2012.
25. Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S and Zanovello P: Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 14: 589, 2013.
26. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT and Giaccia AJ: Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 35: 856-867, 2009.
27. Walter BA, Valera VA, Pinto PA and Merino MJ: Comprehensive microRNA Profiling of Prostate Cancer. J Cancer 4: 350-357, 2013.
28. Ovcharenko D, Kelnar K, Johnson C, Leng N and Brown D: Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67: 10782-10788, 2007.
29. Wang J, Huang W, Wu Y, Hou J, Nie Y, Gu H, Li J, Hu S and Zhang H: MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5. Stem Cells Dev 21: 2508-2519, 2012.
30. Wang Y, Melton C, Li YP, Shenoy A, Zhang XX, Subramanyam D and Blelloch R: miR-294/miR-302 promotes proliferation, suppresses G1-S restriction point, and inhibits ESC differentiation through separable mechanisms. Cell Rep 4: 99-109, 2013.